Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The "Genome Editing: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for genome editing is...
-
Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Global Biochemicals Market 2026-2036" report has been added to ResearchAndMarkets.com's offering. The global biochemicals market represents one of...
-
Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2026 Shenzhen (Shenzhen City, Guangdong Province, China - January 23-24, 2026)" conference has been added to ...
-
Dublin, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The "Advances in Extracellular Vesicle & Biomimetic Science 2025 (Houston, TX, United States - December 1-2, 2025)" conference has been added to ...
-
Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Base Editing Market Size, Share & Trends Analysis Report by Products & Services (Platform, gRNA Design), by Application (Drug Discovery &...
-
Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The global gene therapy market is projected...
-
COVID-19 TESTING LABORATORY SUBSIDIARIES FILE FOR BANKRUPCTY PROTECTION UNIONDALE, NY, Sept. 23, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next...
-
UNIONDALE, NY, Sept. 22, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next generation biotech, genomics and consumer products company, announced that...
-
Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Genome Editing Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.Genome editing, a transformative...
-
ProPhase Labs Stockholders Deliver Strong Mandate at Special Meeting UNIONDALE, NY, Sept. 12, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase” or the “Company”), a next...